Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical Pharmacology

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BCP.2007.06.003PMID 17626785PMCID PMC2000832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.

  2007cited by this paper
• Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.

  2007cited by this paper
• Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A3 adenosine receptor ligands

  2006cited by this paper
• A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro

  2006cited by this paper
• Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post‐ischaemic inhibition of neuronal function in rat hippocampus in vitro

  2006cited by this paper
• Activation of adenosine A3 receptors reduces ischemic brain injury in rodents

  2006cited by this paper
• Adenosine receptors as therapeutic targets

  2006cited by this paper
• A 3 adenosine receptors: Synthesis and biological evaluation of new potent and selective ligands

  2005cited by this paper
• The usefulness of the Korean version of modified Mini-Mental State Examination (K-mMMSE) for dementia screening in community dwelling elderly people

  2004cited by this paper
• Activation of A $_3$ receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons

  2003cited by this paper
• Medicinal chemistry of adenosine A3 receptor ligands.

  2003cited by this paper
• Brief, repeated, oxygen‐glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors

  2003cited by this paper
• Adenosine A3 receptors are located in neurons of the rat hippocampus

  2003cited by this paper
• Behavioral Characterization of Mice Lacking the A3 Adenosine Receptor: Sensitivity to Hypoxic Neurodegeneration

  2003cited by this paper
• A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation.

  2002cited by this paper
• Involvement of mitogen protein kinase cascade in agonist-mediated human A(3) adenosine receptor regulation.

  2002cited by this paper
• N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.

  2002cited by this paper
• Modulation of the rat hippocampal dinucleotide receptor by adenosine receptor activation.

  2002cited by this paper
• The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events.

  2001cited by this paper
• Activation of Synaptic NMDA Receptors by Action Potential-Dependent Release of Transmitter during Hypoxia Impairs Recovery of Synaptic Transmission on Reoxygenation

  2001cited by this paper
• Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.

  2001cited by this paper
• Mechanisms of spreading depression and hypoxic spreading depression-like depolarization.

  2001cited by this paper
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cited by this paper
• Adenosine in the central nervous system: release mechanisms and extracellular concentrations

  2001cited by this paper
• Subtype-specific kinetics of inhibitory adenosine receptor internalization are determined by sensitivity to phosphorylation by G protein-coupled receptor kinases.

  2000cited by this paper
• Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor.

  2000cited by this paper
• Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization.

  2000cited by this paper
• Agonist‐Induced Internalization and Recycling of the Human A3 Adenosine Receptors

  2000cited by this paper
• Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices

  1999cited by this paper
• Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices

  1999cited by this paper
• Adenosine A3 receptors: novel ligands and paradoxical effects.

  1998cited by this paper
• Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions.

  1998cited by this paper
• Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection.

  1998cited by this paper
• Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

  1998cited by this paper
• Protein Kinase C and A3 Adenosine Receptor Activation Inhibit Presynaptic Metabotropic Glutamate Receptor (mGluR) Function and Uncouple mGluRs from GTP-Binding Proteins

  1998cited by this paper
• Factors that reverse the persistent depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro.

  1997cited by this paper
• Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro.

  1997cited by this paper
• Activation of Hippocampal Adenosine A3 Receptors Produces a Desensitization of A1 Receptor-Mediated Responses in Rat Hippocampus

  1997cited by this paper
• Tissue distribution of adenosine receptor mRNAs in the rat

  1996cited by this paper
• Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors

  1996influential reference
• Modification of A‐i and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat

  1995cited by this paper
• Agonist-dependent Phosphorylation and Desensitization of the Rat A3 Adenosine Receptor

  1995cited by this paper
• G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.

  1995cited by this paper
• Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.

  1995cited by this paper
• Endogenous adenosine exerts inhibitory effects upon the development of spreading depression and glutamate release induced by microdialysis with high K+ in rat hippocampus.

  1994cited by this paper
• Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

  1994cited by this paper
• A selective agonist affinity label for A3 adenosine receptors.

  1994cited by this paper
• Adenosine A3 receptor stimulation and cerebral ischemia.

  1994cited by this paper
• Endogenous adenosine delays the onset of hypoxic depolarization in the rat hippocampus in vitro via an action at A1 receptors.

  1993cited by this paper
• Investigations into the Adenosine Outflow from Hippocampal Slices Evoked by Ischemia‐Like Conditions

  1993cited by this paper
• Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

  1992cited by this paper

• Adenosine receptors as emerging therapeutic targets in epilepsy

  2026cites this paper
• Structural Simplification from Tricyclic to Bicyclic Scaffolds: A Long-Term Investigation in the Field of Adenosine Receptor Antagonists

  2025cites this paper
• GPCRs in traumatic brain or spinal injury.

  2025cites this paper
• Inhibition of ADORA3 accelerates hematoma resolution and neurological recovery after ICH.

  2025cites this paper
• Adenosine Receptors in Neuroinflammation and Neurodegeneration

  2025cites this paper
• Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injury

  2024cites this paper
• Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature

  2024cites this paper
• The role of the ATP-adenosine axis in ischemic stroke

  2023cites this paper
• Selective block of adenosine A2A receptors prevents ischaemic‐like effects induced by oxygen and glucose deprivation in rat medium spiny neurons

  2022cites this paper
• Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System

  2022cites this paper
• Protective effects of carbonic anhydrase inhibition in brain ischaemia in vitro and in vivo models

  2021cites this paper
• Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors

  2021cites this paper
• G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential

  2021cites this paper
• Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases

  2020cites this paper
• Prolyl hydroxylase domain inhibitors: can multiple mechanisms be an opportunity for ischemic stroke?

  2019cites this paper
• Adenosine receptors in modulation of central nervous system disorders.

  2019cites this paper
• A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A3 receptor

  2019cites this paper
• The Selective Antagonism of Adenosine A2B Receptors Reduces the Synaptic Failure and Neuronal Death Induced by Oxygen and Glucose Deprivation in Rat CA1 Hippocampus in Vitro

  2018cites this paper
• Pharmacology of Adenosine Receptors: The State of the Art.

  2018cites this paper
• A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy

  2018cites this paper
• Adenosine Receptors: Structure, Distribution, and Signal Transduction

  2018cites this paper
• Hypoxic Preconditioning: The Multiplicity of Central Neurotransmitter Mechanisms and Method of Predicting Its Efficiency

  2018cites this paper
• Hypoxic Preconditioning: The Multiplicity of Central Neurotransmitter Mechanisms and Method of Predicting Its Efficiency

  2018cites this paper
• Adenosine and Oxygen/Glucose Deprivation in the Brain

  2017cites this paper
• Plant Hormone Cytokinins for Modulating Human Aging and Age-Related Diseases

  2017cites this paper
• Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes.

  2017cites this paper
• Dexmedetomidine promotes the recovery of the field excitatory postsynaptic potentials (fEPSPs) in rat hippocampal slices exposed to oxygen-glucose deprivation.

  2016cites this paper
• Purinergic signalling in brain ischemia.

  2016cites this paper
• Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation.

  2015cites this paper
• The A3 Adenosine Receptor: History and Perspectives

  2015cites this paper
• Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R

  2015cites this paper
• 1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.

  2015cites this paper
• Adenosine receptors in cerebral ischemia.

  2014cites this paper
• Intercellular Communication and Heterosynaptic Metaplasticity in the Rodent Hippocampus

  2014cites this paper
• The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches

  2013cites this paper
• Adenosine and Stroke

  2013cites this paper
• Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies.

  2013cites this paper
• Effects of oxygen and glucose deprivation on synaptic transmission in rat dentate gyrus: role of A2A adenosine receptors.

  2013cites this paper
• CXCL16 Orchestrates Adenosine A3 Receptor and MCP-1/CCL2 Activity to Protect Neurons from Excitotoxic Cell Death in the CNS

  2012cites this paper
• Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction

  2012cites this paper
• 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies.

  2012cites this paper
• Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications.

  2012cites this paper
• From A1 to A3 en passant through A(2A) receptors in the hippocampus: pharmacological implications.

  2012cites this paper
• The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.

  2011cites this paper
• Purinergic signalling: from normal behaviour to pathological brain function.

  2011cites this paper
• The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors.

  2011cites this paper
• A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.

  2011cites this paper
• Adenosine receptor desensitization and trafficking.

  2011cites this paper
• Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling

  2011cites this paper
• P2 receptor antagonists prevent synaptic failure and extracellular signal‐regulated kinase1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro

  2011influential citation
• Adenosine A 3 Receptor Signaling in the Central Nervous System

  2010cites this paper
• The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells.

  2010cites this paper
• The Function Analysis Between Ischemia Response-Related Genes In Eight Liver Cell Types And Rat Liver Regeneration

  2010cites this paper
• Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death

  2010cites this paper
• CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes.

  2010influential citation
• Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies.

  2009cites this paper
• Adenosine Neuromodulation and Traumatic Brain Injury

  2009cites this paper
• The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen‐glucose deprivation in rat CA1 hippocampal slices

  2009cites this paper
• A3 adenosine receptor: pharmacology and role in disease.

  2009cites this paper
• Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

  2009cites this paper
• Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

  2009cites this paper
• Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant

  2009cites this paper
• Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

  2009cites this paper
• The adenosine kinase hypothesis of epileptogenesis.

  2008cites this paper
• Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.

  2008cites this paper